Monograph Reform Legislation In Play As FDA, OTC Industry Get Real On Changes

FDA and CHPA preparing for changes to monograph procedures the agency and industry negotiated, including a user fee program, and are included in legislation passed by House and introduced in Senate. But neither the agency nor the trade group expects to be entirely ready before the legislation passes, whenever that might be.

RulesRegulationsBooks_1200x675

Overhauling the US Food and Drug Administration's OTC drug monograph program depends on Congress passing legislation, something agency officials and industry stakeholders are confident will come but aren't predicting when.

The FDA and the Consumer Healthcare Products Association are preparing for changes to monograph procedures that the agency and industry...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation